DEA trades 34.6% above Wall Street's consensus target of $16.41.
Last 12 months price action with 12-month analyst target path
The base valuation assumes DEA achieves its forward estimates and maintains a stable P/E multiple of 139.3x. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 7, 2026, Easterly Government Properties, Inc. (DEA) has a Wall Street consensus price target of $16.41, based on estimates from 8 covering analysts. With the stock currently trading at $25.08, this represents a potential downside of -34.6%. The company has a market capitalization of $1.16B.
Analyst price targets range from a low of $11.00 to a high of $26.45, representing a 94% spread in expectations. The median target of $14.00 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 1 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 1 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, DEA trades at a trailing P/E of 86.5x and forward P/E of 139.3x. Analysts expect EPS to grow -43.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $53.48, with bear and bull scenarios of $33.69 and $70.47 respectively. Model confidence stands at 49/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
CTRECareTrust REIT, Inc. | $9.8B | $41.39 | $44.25 | +6.9% | Buy | 27.7x | 19 |
GMREGlobal Medical REIT Inc. | $94M | $35.74 | $40.00 | +11.9% | Buy | 595.7x | 22 |
GOODGladstone Commercial Corporation | $616M | $12.72 | $14.00 | +10.1% | Buy | 56.1x | 14 |
GTYGetty Realty Corp. | $2.1B | $34.00 | $34.50 | +1.5% | Buy | 21.3x | 13 |
VNOVornado Realty Trust | $7.7B | $40.70 | $36.38 | -10.6% | Hold | 3876.2x | 29 |
BXPBXP, Inc. | $11.2B | $69.97 | $65.50 | -6.4% | Buy | 33.8x | 42 |
HIWHighwoods Properties, Inc. | $3.5B | $31.98 | $28.00 | -12.4% | Hold | 29.8x | 22 |
PDMPiedmont Office Realty Trust, Inc. | $1.2B | $9.62 | $11.00 | +14.3% | Hold | — | 11 |
CIOCity Office REIT, Inc. | $282M | $6.99 | $15.00 | +114.6% | Hold | — | 8 |
PGREParamount Group, Inc. | $1.5B | $6.60 | $8.47 | +28.3% | Hold | — | 13 |
Quick answers to the most common questions about buying DEA stock.
DEA's consensus price target is $16.41, -34.6% below the current price of $25.08. The 8 analysts tracking DEA see downside risk at present valuations.
DEA has a consensus rating of "Hold" based on 8 Wall Street analysts. The rating breakdown is mixed, with 6 Hold ratings making up the largest segment. The consensus 12-month price target of $16.41 implies -34.6% downside from current levels.
At a forward P/E of 139.3333x, DEA trades at a premium valuation. The consensus price target of $16.41 (-34.6% downside) suggests analysts may view current valuations as stretched.
The most bullish Wall Street analyst has a price target of $26.45 for DEA, while the most conservative target is $11. The consensus of $16.41 represents the median expectation. Our quantitative valuation model projects a bull case target of $70 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
DEA is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 6 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month DEA stock forecast based on 8 Wall Street analysts shows a consensus price target of $16.41, with estimates ranging from $11 (bear case) to $26.45 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $53, with bear/bull scenarios of $34/$70.
Our quantitative valuation model calculates DEA's fair value at $53 (base case), with a bear case of $34 and bull case of $70. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 49/100.
DEA trades at a forward P/E ratio of 139.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 86.5x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on DEA, with 1 Sell ratings and a price target of $16.41 (-34.6% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
DEA analyst price targets range from $11 to $26.45, a 94% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $16.41 consensus represents the middle ground. Our model's $34-$70 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.